UNIVERSAL HEALTH SVCS ($UHS) posted quarterly earnings results for Q2 2026 on Monday, July 27th. The company reported earnings of $5.98 per share, missing estimates of $6.02 by $0.04. The company also reported revenue of $4,638,010,000, beating estimates of $4,622,683,544 by $15,326,456.
You can see Quiver Quantitative's $UHS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
UNIVERSAL HEALTH SVCS Insider Trading Activity
UNIVERSAL HEALTH SVCS insiders have traded $UHS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $UHS stock by insiders over the last 6 months:
- ELLIOT J MD MBA SUSSMAN has made 0 purchases and 2 sales selling 674 shares for an estimated $128,099.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
UNIVERSAL HEALTH SVCS Hedge Fund Activity
We have seen 255 institutional investors add shares of UNIVERSAL HEALTH SVCS stock to their portfolio, and 341 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 514,685 shares (-28.1%) from their portfolio in Q1 2026, for an estimated $92,113,174
- GLENVIEW CAPITAL MANAGEMENT, LLC removed 482,169 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $86,293,785
- MORGAN STANLEY removed 253,780 shares (-29.1%) from their portfolio in Q1 2026, for an estimated $45,419,006
- MILLENNIUM MANAGEMENT LLC added 230,177 shares (+50.3%) to their portfolio in Q1 2026, for an estimated $41,194,777
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 206,013 shares (+660.2%) to their portfolio in Q1 2026, for an estimated $36,870,146
- PZENA INVESTMENT MANAGEMENT LLC removed 200,369 shares (-9.5%) from their portfolio in Q1 2026, for an estimated $35,860,039
- GEODE CAPITAL MANAGEMENT, LLC added 196,046 shares (+11.2%) to their portfolio in Q1 2026, for an estimated $35,086,352
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
UNIVERSAL HEALTH SVCS Congressional Stock Trading
Members of Congress have traded $UHS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $UHS stock by members of Congress over the last 6 months:
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
UNIVERSAL HEALTH SVCS Analyst Ratings
Wall Street analysts have issued reports on $UHS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 04/29/2026
To track analyst ratings and price targets for UNIVERSAL HEALTH SVCS, check out Quiver Quantitative's $UHS forecast page.
UNIVERSAL HEALTH SVCS Price Targets
Multiple analysts have issued price targets for $UHS recently. We have seen 8 analysts offer price targets for $UHS in the last 6 months, with a median target of $195.5.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $179.0 on 07/08/2026
- Ryan Langston from TD Cowen set a target price of $197.0 on 06/22/2026
- Stephen Baxter from Wells Fargo set a target price of $165.0 on 06/01/2026
- A.J. Rice from UBS set a target price of $310.0 on 04/30/2026
- Michael Ha from Baird set a target price of $204.0 on 04/29/2026
- Sarah James from Cantor Fitzgerald set a target price of $194.0 on 04/29/2026
- Ben Hendrix from RBC Capital set a target price of $190.0 on 04/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
